- Net income flipped to a loss of $(8.05)M in Q3 2026 vs. $3.73M in Q3 2025 (diluted EPS $(0.04) vs. $0.02).
- CEO noted medical expense trends ran higher than internal expectations.
- Cash and cash equivalents stood at $727.7M as of September 30, 2026.
?? Negative AI Sentiment (-4.0 / 10)